app-store-icon play-store-icon
Earnings Review: Sun Pharma beats Street view on all-round show

Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.Real-Time EquityWire is available only to registered users. This is best for professional traders and people who track markets actively.

Please register for a 30-day free trial. Click here
Earnings Review

Sun Pharma beats Street view on all-round show

This story was originally published at 18:22 IST on May 22, 2024  Back
Register to read our real-time news.


Robust all-round performance, be it the speciality pharma business, the India formulations business, US markets, combined with lower raw material costs, tax and finance costs, helped Sun Pharmaceutical Industries Ltd to report better than expected consolidated net profit and revenue for the March quarter.

To read our premium stories please subscribe.